Class 4 Medicines Defect Notification: Erythromycin Stearate Bp 250mg Tablets, Amdipharm UK Ltd, El(25)a/32
Recall Summary Amdipharm UK Ltd is recalling a batch of Erythromycin Stearate BP 250mg tablets because the patient information leaflet included in the carton is outdated. The affected batch was distributed in the United Kingdom.
- Recalling firm
- Erythromycin Stearate BP 250mg Tablets
- Reason
- Amdipharm UK Ltd has informed MHRA that the Patient information leaflet (PIL) in the cartons for the batch listed in this notification includes a superseded PIL.
- Classification
- Class III
- Category
- drug recall
- Country
- United Kingdom
- Agency
- UK Medicines and Healthcare products Regulatory Agency
- Recall date
- 2025-07-01
- Status
- Ongoing
- Distribution
- United Kingdom
Official recall notice from UK Medicines and Healthcare products Regulatory Agency
Recall details on Nibble Recalls: https://trynibble.app/recalls/c78e5d94-5c14-4dfb-81f0-fdb141186968